Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Correlation of Fc gamma RIIIA receptor expression and response to rituximab and other monoclonal antibodies in patients with Waldenstrom's macroglobulinemia

X
Trial Profile

Correlation of Fc gamma RIIIA receptor expression and response to rituximab and other monoclonal antibodies in patients with Waldenstrom's macroglobulinemia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Monoclonal antibodies; Rituximab
  • Indications Waldenstrom's macroglobulinaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2011 Biomarkers information updated
    • 22 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 20 Dec 2007 Status changed from recruiting to discontinued. According to Clinicaltrials.gov this study has been "terminated due to continuing review".

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top